Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

YY-A02-B Overlapped Compression Therapy

K-Number: K221862 · 2022-12-08

Decision Date2022-12-08
Product CodeIRP
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

YY-A02-B Overlapped Compression Therapy is a medical device manufactured by Huizhou Xinyi Technology Co., Ltd.. It received FDA 510(k) clearance on 2022-12-08 under approval number K221862. The device is classified under product code IRP. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the YY-A02-B Overlapped Compression Therapy?

YY-A02-B Overlapped Compression Therapy is a medical device that received FDA 510(k) clearance on 2022-12-08. It is manufactured by Huizhou Xinyi Technology Co., Ltd.. The 510(k) number is K221862.

When was YY-A02-B Overlapped Compression Therapy approved by the FDA?

YY-A02-B Overlapped Compression Therapy received FDA 510(k) clearance on 2022-12-08, under approval number K221862.

What company makes YY-A02-B Overlapped Compression Therapy?

YY-A02-B Overlapped Compression Therapy is manufactured by Huizhou Xinyi Technology Co., Ltd..

What is the FDA product code for YY-A02-B Overlapped Compression Therapy?

The FDA product code for YY-A02-B Overlapped Compression Therapy is IRP.

Related Clinical Trials

Other Devices by Huizhou Xinyi Technology Co., Ltd.

Related Devices (Code: IRP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.